# EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
> **ANDA091593** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2012-02-27
## Drug
- **FDA Application Number:** ANDA091593
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** Efavirenz
- **Active ingredients:** EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2012-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091593)
---
*MORVS · CC0 1.0*